HC Wainwright & Co. Initiates Coverage On AngioDynamics with Buy Rating, Announces Price Target of $19
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has initiated coverage on AngioDynamics with a Buy rating and a price target of $19.
September 25, 2023 | 10:14 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AngioDynamics has been given a Buy rating by HC Wainwright & Co. with a price target of $19.
The Buy rating and price target of $19 by HC Wainwright & Co. indicates a positive outlook for AngioDynamics. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100